0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.83%
Revenue growth at 50-75% of 3606.HK's 13.27%. Martin Whitman would worry about competitiveness or product relevance.
2.90%
Gross profit growth under 50% of 3606.HK's 18.05%. Michael Burry would be concerned about a severe competitive disadvantage.
6.20%
EBIT growth 50-75% of 3606.HK's 12.20%. Martin Whitman would suspect suboptimal resource allocation.
35.35%
Operating income growth above 1.5x 3606.HK's 21.34%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-19.07%
Negative net income growth while 3606.HK stands at 15.01%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-9.25%
Negative EPS growth while 3606.HK is at 15.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.78%
Negative diluted EPS growth while 3606.HK is at 15.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-10.94%
Share reduction while 3606.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-14.43%
Reduced diluted shares while 3606.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
349.14%
Dividend growth under 50% of 3606.HK's 1913.90%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-29.11%
Negative OCF growth while 3606.HK is at 134.15%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-271.62%
Negative FCF growth while 3606.HK is at 1917.90%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
82239.74%
10Y revenue/share CAGR above 1.5x 3606.HK's 567.68%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
44.10%
5Y revenue/share CAGR under 50% of 3606.HK's 94.72%. Michael Burry would suspect a significant competitive gap or product weakness.
12.96%
3Y revenue/share CAGR under 50% of 3606.HK's 39.61%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
565.21%
10Y OCF/share CAGR at 50-75% of 3606.HK's 1091.63%. Martin Whitman might fear a structural deficiency in operational efficiency.
-83.91%
Negative 5Y OCF/share CAGR while 3606.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-64.35%
Negative 3Y OCF/share CAGR while 3606.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
467.39%
Net income/share CAGR 1.25-1.5x 3606.HK's 400.03%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-50.51%
Negative 5Y net income/share CAGR while 3606.HK is 86.25%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-54.74%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
104.46%
3Y equity/share CAGR above 1.5x 3606.HK's 39.30%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-29.68%
Negative 5Y dividend/share CAGR while 3606.HK stands at 226.57%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-88.67%
Negative near-term dividend growth while 3606.HK invests at 209.16%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
-2.99%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.78%
Negative asset growth while 3606.HK invests at 2.66%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
18.40%
Positive BV/share change while 3606.HK is negative. John Neff sees a clear edge over a competitor losing equity.
-30.04%
We’re deleveraging while 3606.HK stands at 55.21%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.76%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.